Physician profile
Jonathan M Lyons
NPI 1104213206
$2,464.77
in general payments reported to CMS, 2019-2025
15 companies · $795 in 2025
The $795 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.45 · 2020: $57.61 · 2021: $138 · 2022: $99.13 · 2023: $279 · 2024: $1,083 · 2025: $795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,157.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $718.88 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $392.77 | 2023-2025 | |
| Abbvie INC. | $386.87 | 2022-2025 | |
| Pfizer INC. | $243.40 | 2020-2024 | |
| Glaxosmithkline, LLC. | $226.40 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Lilly USA, LLC | $134.03 | 2021-2024 | Mounjaro, Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.02 | 2022-2025 | Jardiance |
| Abbott Laboratories | $74.43 | 2024-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit |
| Teva Pharmaceuticals USA, INC. | $54.61 | 2024 | Austedo Xr, Ajovy |
| Novo Nordisk INC | $40.70 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $30.28 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.14 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $17.86 | 2024 | Voquezna |
| Ardelyx, INC. | $16.19 | 2025 | Ibsrela |
| Dexcom, INC. | $14.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Lyons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.